Session Title

AI Beyond the Hype: How Digital Twin Technology is Rewriting Healthcare Outcomes

Session Overview

Every industry talks about AI adoption, but few have moved from experimentation to measurable human impact at scale. At Twin, our revolutionary invention, the "Whole Body Digital Twin™", the first of its kind, has made measuring metabolism at an individual level a reality. Built on an AI-powered precision treatment platform, this technology is reversing chronic metabolic diseases like diabetes, hypertension, fatty liver, PCOS, and cholesterol disorders - conditions long accepted as lifelong, progressive, and managed only through symptom control, often ending in severe complications. Twin is not an AI wrapper company. We have made "AI adoption beyond hype" a reality where the stakes are human health, through bold technical bets, hard failures, genuine breakthroughs, and the principles that made resilience possible. Across the healthcare industry, individual health data has historically been captured at points in time, during occasional physician visits or periodic blood labs. The industry lacked the ability to track continuous health data at the individual level at scale. The Whole Body Digital Twin™ delivers a new standard of care, empowering physicians and patients to make highly personalised, data-driven decisions based on real-time feedback from patients' own bodies, turning what was once reactive symptom management into proactive, precision-driven reversal of disease.